Anesthetic Safety and Perioperative Outcomes in GLP-1 Receptor Agonist-Treated Patients Undergoing Lipoabdominoplasty.

A reassuring data point on the perioperative question that has dominated anesthesiology guidance since 2023, but a limited one: retrospective, single-protocol, and the authors themselves stress it was not powered for equivalence or for rare events such as aspiration. Absence of a detected signal in 98 exposed patients is not proof of safety. Useful context for patients planning body-contouring surgery after GLP-1 weight loss, not a basis to relax pre-operative precautions.